PMV Pharmaceuticals, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

PMVP

organization

SIC: 2834

SEC Insider

$136.1M

456 transactions

Summary

PMV Pharmaceuticals, Inc. (PMVP) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $72.4MSales: $61.9M47 insiders

Date	Insider	Type	Value
2025-10-23	Joint reporting: ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC	Sell	$1.5M
2025-09-10	Joint reporting: ORBIMED ADVISORS LLC; OrbiMed Capital GP V LLC	Sell	$900K
2025-10-27	Mack David Henry(President and CEO)	M	$302K
2025-07-01	Mack David Henry(President and CEO)	Sell	$62K
2025-07-01	Jalota Deepika(Chief Development Officer)	Sell	$35K
2025-07-01	Carulli Michael(Chief Financial Officer)	Sell	$30K
2025-07-01	Ticktin Robert(General Counsel & COO)	Sell	$25K
2026-06-04	LEVINE ARNOLD J	A	$0
2026-06-04	Gallagher Carol Giltner	A	$0
2026-06-04	Gallagher Carol Giltner	G	$0
2026-06-04	Gallagher Carol Giltner	G	$0
2026-06-04	BAUM CHARLES M	A	$0
2026-06-04	Stelzer Laurie	A	$0
2026-06-04	FLOWERS KIRSTEN	A	$0
2026-03-05	Mack David Henry(President and CEO)	A	$0
2026-03-05	Ticktin Robert(General Counsel & COO)	A	$0
2026-03-05	Jalota Deepika(Chief Development Officer)	A	$0
2026-03-05	Carulli Michael(Chief Financial Officer)	A	$0
2025-10-27	Mack David Henry(President and CEO)	M	$0
2025-06-05	BAUM CHARLES M	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

PMV Pharmaceuticals, Inc. — Contributions, Lobbying & Contracts | Poliscope